Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT02162251
Eligibility Criteria:
Inclusion criteria:
Patients diagnosed with Alzheimer's Disease who are to be administered both donepezil hydrochloride and memantine hydrochloride in clinical practice.
Exclusion criteria:
Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02162251
Study Brief:
Protocol Section:
NCT02162251